Skip to search.
 TSX Up 0.65% TSX Ventures Down 0.16%

More On TTH.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transition Therapeutics Inc (TTH.TO)

-Toronto
8.60 Up 0.10(1.18%) Mar 30, 3:34PM EDT
Add to Portfolio
Prev Close:8.50
Open:8.60
Bid:8.00
Ask:8.85
1y Target Est:N/A
Beta:0.66
Earnings Date:May 6 - May 15 (Est.)
Day's Range:8.60 - 8.60
52wk Range:4.80 - 9.47
Volume:165
Avg Vol (3m):1,202
Market Cap:302.97M
P/E (ttm):N/A
EPS (ttm):-1.53
Div & Yield:0.06 (0.20%)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:29-Dec-10

Analysts

Annual EPS Est (Jun-15) :-1.31
Quarterly EPS Est (Mar-15) :-0.17
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback